Login to Your Account

China’s blood product makers face potentially challenging year

By Cornelia Zou
Staff Writer

Wednesday, December 18, 2013

HONG KONG – The market for expensive blood products in China is attracting biotech companies looking to boost their bottom lines, but a surge in imports, driven by high supply levels abroad, is pressuring the bottom lines of domestic suppliers.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription